 SAN FRANCISCO, Jan. 24, 2023 GLOBE NEWSWIRE Hagens Berman urges Y-mAbs Therapeutics, Inc. NASDAQ: YMAB investors who suffered significant losses to submit your losses now. Class Period: Oct. 6, 2020 Oct. 28, 2022 Lead Plaintiff Deadline: Mar. 20, 2023 Visit: Contact An Attorney Now: 844-916-0895 Y-mAbs Therapeutics, Inc. NASDAQ: YMAB ... The post YMAB DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Y-mAbs Thera... 